Eraneos search results

AI in Action: Demonstrators for Clinical Trials and Document QA

Three working AI demos for pharma: document redaction, PDF quality checks, and TMF integrity monitoring built on real clinical trial workflows.

Whitepaper 27 May 2026

AI Transformation in Pharma with Veeva and Trusted Data Foundations

Explore how pharma companies use Veeva, AI, and trusted data foundations to scale compliant AI transformation and accelerate business value.

Whitepaper 27 May 2026

From Veeva Investment to AI Transformation

Eraneos helps life sciences organisations turn their Veeva investment into a launchpad for scalable AI transformation.

Whitepaper 27 May 2026

GPT & LLM Use Cases for Pharma Manufacturing

Explore 20 practical GPT and LLM use cases for pharma manufacturing. Eraneos maps non-GxP and GxP scenarios by effort and impact to help teams prioritise AI adoption.

Whitepaper 27 May 2026

Data Quality Management & Readiness in Clinical Trials

Eraneos helped a global pharma company improve data readiness across Veeva CTMS — reducing manual rework and building governance for reliable clinical trials.

Whitepaper 27 May 2026

From complexity to control: implementing site payments in Veeva

Learn how Eraneos helps sponsors implement site payments in Veeva. A structured approach across alignment, process design, enablement and adoption.

Whitepaper 20 May 2026

DEUS joins Eraneos to build European AI transformation powerhouse

Eraneos expands AI capabilities by partnering with DEUS to help organizations evolve from AI experimentation to empowered AI leadership.

Press release 19 May 2026

Building an AI-empowered organization: Human-centric and agentic AI transformation

AI transformation demands more than pilots. Discover the framework that closes the value and trust gap, and turns AI ambition into enterprise results.

Infographic 18 May 2026

Preparing for Q-Day: a practical roadmap to quantum-resilient cryptography

Q-Day could break RSA and ECC cryptography. Learn how organizations can reduce quantum risk through cryptographic agility and early preparation.

Article 13 May 2026

TLS 1.3 hybrid KEM in post-quantum cryptography migration

Learn how TLS 1.3 hybrid KEM supports post-quantum cryptography migration by strengthening confidentiality against “harvest now, decrypt later” attacks.

Article 13 May 2026